HFNC and Prone Positioning in Awake Patients With Severe COVID-19
NCT ID: NCT04982341
Last Updated: 2021-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2020-09-02
2021-03-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS
NCT04325906
COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss
NCT04395144
Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure
NCT05866289
Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure
NCT04641182
Characteristics and Outcomes of Patients With COVID-19 Treated With HFNO and Prone Positioning
NCT05178212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients with ARF related to Covid-19 and admitted to the ICU are turned in prone position whenever tolerated, while receiving oxygenation with HFNC.
Outcomes of interest are the rate of success or failure (defined as the need for intubation and mechanical ventilation)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HFNC/prone
awake patients with COVID-19 and severe acute respiratory failure receiving HFNC in prone position
prone position
patients are returned from prone to supine position while receiving oxygenation through HFNC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prone position
patients are returned from prone to supine position while receiving oxygenation through HFNC
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital Universitaire Fattouma Bourguiba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fekri Abroug
Professor Head of the ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lamia Besbes, Prof
Role: STUDY_CHAIR
CPPRB
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU F.Bourguiba
Monastir, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FattoumaBourguiba_HFNC_Prone
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.